Prognostic factors in patients who received end-of-life chemotherapy for advanced cancer

Prognostic factors in patients who received end-of-life chemotherapy for advanced cancer

Background Clinical efficacy of aggressive end-of-life (EOL) chemotherapy remains unclear. Method Medical records of patients with advanced cancer between August 2011 and August 2016 were retrospectively analyzed. The primary endpoint was to identify prognostic factors at the last administration of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of clinical oncology 2019-04, Vol.24 (4), p.454-459
Hauptverfasser: Hiramoto, Shuji, Tamaki, Tomoko, Nagashima, Kengo, Hori, Tetsuo, Kikuchi, Ayako, Yoshioka, Akira, Inoue, Akira
Format: Artikel
Sprache:eng
Schlagworte:
Cancer
Cancer Research
Chemotherapy
Decision making
Medical prognosis
Medical records
Medicine
Medicine & Public Health
Multivariate analysis
Nausea
Oncology
Original Article
Patients
Surgical Oncology
Vomiting
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Clinical efficacy of aggressive end-of-life (EOL) chemotherapy remains unclear. Method Medical records of patients with advanced cancer between August 2011 and August 2016 were retrospectively analyzed. The primary endpoint was to identify prognostic factors at the last administration of chemotherapy. The secondary endpoint was to analyze the relationship between EOL symptoms and EOL treatment details. Results Among 300 evaluated patients, the number of patients who died within 14 and 30 days from the last administration of chemotherapy were 16 (5.3%) and 50 (16.7%), respectively. Multivariate analysis revealed that ECOG-PS (OR 3.698, p  
ISSN:1341-9625
1437-7772
DOI:10.1007/s10147-018-1363-7